# HITS funding rounds and investors

As of 13 Nov 2026, HITS has raised $13.7M across 1 verified round on record (amounts in other currencies converted to USD); latest: 18.3 billion won Series B led by Premier Partners, announced Sep 2026.

HITS is a Korean AI drug discovery company and the maker of the HyperLab drug discovery platform.

Website: https://hits.ai  
Headquarters: Gangnam District, Seoul  
Page: https://fireround.dev/companies/hits

## Verified rounds

| Announced | Round | Amount | Lead investors | Other investors | Sources |
| --- | --- | --- | --- | --- | --- |
| 2026-09 | Series B | 18.3 billion won | Premier Partners | BSK Investment, Capsule Partners, IBK Venture Investment, Korea Investment Partners, Laplace Partners, Samsung Securities, TBT Partners, Yuanta Investment | [biz.chosun.com](https://biz.chosun.com/en/en-science/2026/09/28/BHPMDZ63EZEDPC6T4OXNBICT5U), [finance.biggo.com](https://finance.biggo.com/news/e97c151d-d7da-4603-b4dc-1da54842d5ec), [finance.biggo.com](https://finance.biggo.com/s/HITS?hot_keyword=1) |

Source: Fireround (https://fireround.dev), an open-source funding feed. Each round is checked against the pages listed with it.